Anti-neuroblastoma antibodies in myasthenia gravis: clinical and immunological correlations
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 93 (2-3) , 263-275
- https://doi.org/10.1016/0022-510x(89)90196-2
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from ratJournal of the Neurological Sciences, 1988
- Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1987
- CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?Acta Neurologica Scandinavica, 1987
- Clinical correlates of enzyme-immunoassay versus radioimmunoassay measurements of antibody against acetylcholine receptor in patients with myasthenia gravisJournal of the Neurological Sciences, 1986
- Autoantibodies to Neuroblastoma Cell Surface Antigens in Neuropsychiatric LupusNeuropediatrics, 1986
- Myasthenia gravis and myasthenic syndromesAnnals of Neurology, 1984
- The Thy-1 glycoprotein on nerve cells in cultureJournal of Neuroimmunology, 1982
- Autoimmunity in ocular and generalised myasthenia gravisJournal of Neuroimmunology, 1981
- CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVISBrain, 1980
- Studies on Sera from Cases of Myasthenia Gravis, using the Fluorescent Antibody TechniqueVox Sanguinis, 1963